AAAAAA
Results:
1-8
|
Results: 8
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
Authors:
Brockstein, B
Samuels, B
Humerickhouse, R
Arietta, R
Fishkin, P
Wade, J
Sosman, J
Vokes, EE
Citation: B. Brockstein et al., Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer, INV NEW DR, 19(3), 2001, pp. 249-254
Authors:
Sarris, AH
Psyrri, A
Hagemeister, F
Romaguera, J
McLaughlin, P
Rodriguez, MA
Bachier, C
Younes, A
Mesina, O
Oholendt, M
Medeiros, LJ
Samuels, B
Adams, LM
Cabanillas, F
Citation: Ah. Sarris et al., Infusional vinorelbine in relapsed or refractory lymphomas, LEUK LYMPH, 39(3-4), 2000, pp. 291-299
Authors:
Sarris, AH
Hagemeister, F
Romaguera, J
Rodriguez, MA
McLaughlin, P
Tsimberidou, AM
Medeiros, LJ
Samuels, B
Pate, O
Oholendt, M
Kantarjian, H
Burge, C
Cabanillas, F
Citation: Ah. Sarris et al., Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial, ANN ONCOL, 11(1), 2000, pp. 69-72
Authors:
Przepiorka, D
van Besien, K
Khouri, I
Hagemeister, F
Samuels, B
Folloder, J
Ueno, NT
Molldrem, J
Mehra, R
Korbling, M
Giralt, S
Gajewski, J
Donato, M
Cleary, K
Claxton, D
Braunschweig, I
Andersson, B
Anderlini, P
Champlin, R
Citation: D. Przepiorka et al., Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma, ANN ONCOL, 10(5), 1999, pp. 527-532
Authors:
Khouri, IF
Lee, MS
Romaguera, J
Mirza, N
Kantarjian, H
Korbling, M
Albitar, M
Giralt, S
Samuels, B
Anderlini, P
Rodriguez, J
von Wolff, B
Gajewski, J
Cabanillas, F
Champlin, R
Citation: If. Khouri et al., Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy, ANN ONCOL, 10(11), 1999, pp. 1293-1299
Authors:
Mani, S
Sciortino, D
Samuels, B
Arrietta, R
Schilsky, RL
Vokes, EE
Benner, S
Citation: S. Mani et al., Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma, INV NEW DR, 17(1), 1999, pp. 97-101
Authors:
Khouri, IF
Romaguera, J
Kantarjian, H
Palmer, JL
Pugh, WC
Korbling, M
Hagemeister, F
Samuels, B
Rodriguez, A
Giralt, S
Younes, A
Przepiorka, D
Claxton, D
Cabanillas, F
Champlin, R
Citation: If. Khouri et al., Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma, J CL ONCOL, 16(12), 1998, pp. 3803-3809
Authors:
Mani, S
Schiano, T
Garcia, JC
Ansari, RH
Samuels, B
Sciortino, DF
Tembe, S
Shulman, KL
Baker, A
Benner, SE
Vokes, EE
Citation: S. Mani et al., Phase II trial of uracil tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma, INV NEW DR, 16(3), 1998, pp. 279-283
Risultati:
1-8
|